Release Date: 23/07/20 08:29 Summary: Appendix 4C - quarterly Price Sensitive: Yes Download Document 190.47KB Download
MSB Mesoblast resubmits US FDA application for approval of Ryoncil in children with graft vs host disease; shares dip -4%